SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001443
Filing Date
2022-05-13
Accepted
2022-05-13 14:07:59
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eyen-20220331x10q.htm   iXBRL 10-Q 1150774
2 EX-31.1 eyen-20220331xex31d1.htm EX-31.1 15366
3 EX-31.2 eyen-20220331xex31d2.htm EX-31.2 15352
4 EX-32.1 eyen-20220331xex32d1.htm EX-32.1 7307
5 EX-32.2 eyen-20220331xex32d2.htm EX-32.2 7223
  Complete submission text file 0001410578-22-001443.txt   5304500

Data Files

Seq Description Document Type Size
6 EX-101.SCH eyen-20220331.xsd EX-101.SCH 51969
7 EX-101.CAL eyen-20220331_cal.xml EX-101.CAL 40657
8 EX-101.DEF eyen-20220331_def.xml EX-101.DEF 130516
9 EX-101.LAB eyen-20220331_lab.xml EX-101.LAB 320924
10 EX-101.PRE eyen-20220331_pre.xml EX-101.PRE 263974
54 EXTRACTED XBRL INSTANCE DOCUMENT eyen-20220331x10q_htm.xml XML 980157
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38365 | Film No.: 22921812
SIC: 2834 Pharmaceutical Preparations